Skip to content
Life Sciences Series A Founded 2019

InVivo Biosystems

InVivo Biosystems provides animal models for in-vivo analytical services, with disease models including C. elegans for transgenic services and Zebrafish for genome editing. The company offers assay kits, reagents, custom in-vivo testing, and in-vivo toxicity testing. Founded in 2019 in Eugene, United States, the company has raised $8.2M in Series A funding from investors including Rogue Venture Partners and Oregon…

📍 Eugene, United States · Life Sciences Platforms and Tools,

Funding snapshot

Last roundSeries A
Amount$3M
Date26 February 2025
Total raised$8M
Team size43

About

InVivo Biosystems provides animal models for in-vivo analytical services, with disease models including C. elegans for transgenic services and Zebrafish for genome editing. The company offers assay kits, reagents, custom in-vivo testing, and in-vivo toxicity testing. Founded in 2019 in Eugene, United States, the company has raised $8.2M in Series A funding from investors including Rogue Venture Partners and Oregon Venture Fund. InVivo Biosystems provider of animal models for in-vivo analytical services. The company's disease model includes C. elegance for transgenic services and Zebrafish for genome editing services. It also offers assay kit, reagents like PCR master mix, custom in-vivo testing and in-vivo toxicity testing. Founded in 2019, headquartered in Eugene, United States.

Business model

Genomics > Genomics Research > Research Models,

Life Sciences Platforms and Tools > Research Services > Animal Models > Xenograft Models > Zebra Fish models,

Biopharma Outsourcing > CRO > Preclinical Studies > Diversified > InVivo

Institutional investors

Rogue Venture Partners Portland Seed Fund ONAMI Launch Oregon Oregon Venture Fund Cascadia Venture Forum HHS Cascade Seed Fund

Latest coverage

No articles yet.

Raising like InVivo Biosystems?

Analyze your pitch deck before your next raise.

Analyze My Deck →